McKesson Corporation (0JZU.L)
USD 570.25
(1.91%)
USD 570.25
(1.91%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 5.47 Billion USD | 1.8% |
| 2022 | 7.29 Billion USD | -3.27% |
| 2021 | 7.54 Billion USD | -19.81% |
| 2020 | 9.4 Billion USD | 0.04% |
| 2019 | 9.4 Billion USD | 23.78% |
| 2018 | 7.59 Billion USD | -3.62% |
| 2017 | 7.88 Billion USD | -7.78% |
| 2016 | 8.54 Billion USD | 5.31% |
| 2015 | 8.11 Billion USD | -17.57% |
| 2014 | 9.84 Billion USD | -7.09% |
| 2013 | 10.59 Billion USD | 117.42% |
| 2012 | 4.87 Billion USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 5.44 Billion USD | 0.62% |
| 2023 Q1 | 7.42 Billion USD | 1.75% |
| 2023 Q4 | 7.39 Billion USD | -2.87% |
| 2023 Q3 | 7.6 Billion USD | 3.99% |
| 2023 Q2 | 7.31 Billion USD | -1.44% |
| 2023 FY | 7.39 Billion USD | 1.3% |
| 2022 FY | 7.29 Billion USD | -3.27% |
| 2022 Q3 | 8.17 Billion USD | 13.35% |
| 2022 Q2 | 7.21 Billion USD | -2.96% |
| 2022 Q1 | 7.43 Billion USD | -1.46% |
| 2022 Q4 | 7.29 Billion USD | -10.76% |
| 2021 Q2 | 7.93 Billion USD | -16.05% |
| 2021 Q1 | 9.45 Billion USD | 0.54% |
| 2021 FY | 7.54 Billion USD | -19.81% |
| 2021 Q3 | 8.01 Billion USD | 0.94% |
| 2021 Q4 | 7.54 Billion USD | -5.88% |
| 2020 Q2 | 9.34 Billion USD | 2.65% |
| 2020 Q3 | 9.33 Billion USD | -0.13% |
| 2020 Q4 | 9.4 Billion USD | 0.8% |
| 2020 FY | 9.4 Billion USD | 0.04% |
| 2020 Q1 | 9.1 Billion USD | 0.55% |
| 2019 FY | 9.4 Billion USD | 23.78% |
| 2019 Q3 | 11.67 Billion USD | 17.15% |
| 2019 Q4 | 9.05 Billion USD | -22.44% |
| 2019 Q1 | 9.55 Billion USD | 25.02% |
| 2019 Q2 | 9.96 Billion USD | 4.22% |
| 2018 Q3 | 9.84 Billion USD | 6.88% |
| 2018 FY | 7.59 Billion USD | -3.62% |
| 2018 Q1 | 9.87 Billion USD | 21.8% |
| 2018 Q2 | 9.21 Billion USD | -6.7% |
| 2018 Q4 | 7.64 Billion USD | -22.37% |
| 2017 Q3 | 8.95 Billion USD | 5.96% |
| 2017 Q4 | 8.1 Billion USD | -9.47% |
| 2017 FY | 7.88 Billion USD | -7.78% |
| 2017 Q1 | 7.97 Billion USD | -6.64% |
| 2017 Q2 | 8.45 Billion USD | 5.95% |
| 2016 Q1 | 8.11 Billion USD | -0.15% |
| 2016 Q4 | 8.54 Billion USD | -6.34% |
| 2016 Q3 | 9.12 Billion USD | 12.53% |
| 2016 FY | 8.54 Billion USD | 5.31% |
| 2016 Q2 | 8.1 Billion USD | -0.04% |
| 2015 FY | 8.11 Billion USD | -17.57% |
| 2015 Q4 | 8.12 Billion USD | -6.84% |
| 2015 Q3 | 8.71 Billion USD | -7.14% |
| 2015 Q2 | 9.38 Billion USD | -4.16% |
| 2015 Q1 | 9.79 Billion USD | -0.49% |
| 2014 Q1 | 10.67 Billion USD | 0.74% |
| 2014 Q4 | 9.84 Billion USD | -5.29% |
| 2014 Q3 | 10.39 Billion USD | -1.68% |
| 2014 Q2 | 10.57 Billion USD | -0.95% |
| 2014 FY | 9.84 Billion USD | -7.09% |
| 2013 Q1 | 4.87 Billion USD | 0.02% |
| 2013 Q2 | 4.87 Billion USD | 0.0% |
| 2013 Q3 | 4.87 Billion USD | 0.0% |
| 2013 Q4 | 10.59 Billion USD | 117.38% |
| 2013 FY | 10.59 Billion USD | 117.42% |
| 2012 Q4 | 4.87 Billion USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | 4.87 Billion USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Phreesia, Inc. | 11.98 Million USD | -45564.692% |
| Accuray Incorporated | 172.15 Million USD | -3078.513% |
| Align Technology, Inc. | 96.96 Million USD | -5543.099% |
| Elevance Health Inc. | 25.12 Billion USD | 78.217% |
| AxoGen, Inc. | 69.29 Million USD | -7797.016% |
| Boston Scientific Corporation | 9.09 Billion USD | 39.848% |
| CVS Health Corporation | 79.38 Billion USD | 93.107% |
| Cardinal Health, Inc. | 5.6 Billion USD | 2.443% |
| Centene Corporation | 17.69 Billion USD | 69.083% |
| DaVita Inc. | 11.11 Billion USD | 50.776% |
| HCA Healthcare, Inc. | 41.85 Billion USD | 86.928% |
| Hologic, Inc. | 2.53 Billion USD | -115.892% |
| Humana Inc. | 10.21 Billion USD | 46.421% |
| IDEXX Laboratories, Inc. | 947.88 Million USD | -477.288% |
| Laboratory Corporation of America Holdings | 5.95 Billion USD | 8.098% |
| Masimo Corporation | 970 Million USD | -464.124% |
| Patterson Companies, Inc. | 762.94 Million USD | -617.225% |
| Quest Diagnostics Incorporated | 5.36 Billion USD | -1.918% |
| ResMed Inc. | 873.93 Million USD | -526.134% |
| Henry Schein, Inc. | 2.74 Billion USD | -99.635% |
| Teladoc Health, Inc. | 1.59 Billion USD | -243.659% |
| Universal Health Services, Inc. | 5.36 Billion USD | -1.963% |
| Veeva Systems Inc. | 55.77 Million USD | -9710.847% |
| Baxter International Inc. | 14.36 Billion USD | 61.905% |
| Becton, Dickinson and Company | 15.87 Billion USD | 65.539% |
| Intuitive Surgical, Inc. | 89.8 Million USD | -5993.541% |
| Danaher Corporation | 19.35 Billion USD | 71.73% |
| Stryker Corporation | 12.99 Billion USD | 57.891% |
| Medtronic plc | 24.96 Billion USD | 78.08% |